Clinical Trials Directory

Trials / Completed

CompletedNCT01387620

Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2%

Intraindividual Randomized Clinical Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2% in Phacoemulsification

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
39 (actual)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
50 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This prospective study was performed to compare two ophthalmic viscosurgical devices, DisCoVisc (hyaluronic acid 1.6% - chondroitin sulfate 4.0%) and hydroxypropylmethylcellulose 2% in terms of their overall clinical performance during phacoemulsification.

Conditions

Interventions

TypeNameDescription
DRUGHyaluronic Acid and hydroxypropylmethylcelluloseHyaluronic Acid 1.6% was used to performed phacoemulsification in one eye and hydroxypropylmethylcellulose 2% was used in the fellow eye.

Timeline

Start date
2009-06-01
Primary completion
2010-02-01
Completion
2010-12-01
First posted
2011-07-04
Last updated
2011-07-04

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01387620. Inclusion in this directory is not an endorsement.